![Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition) Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2444050717300761:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNdvmYPHt6bjyzOpfOlwJvwGBYc//ZwJBYMynuudQpd+r5uPgZn3Bk8bAnXmG/cZzggr8+Nhc/NIJ0RJJbkMNDWz98QaCsdYhUGqRFnAAM+isbIo1ebmdOETlhak8TUYhmbSXaCrOjF/5Gk4czEghiHsxjIwunYUS5qAabn/HLBYApGB3L2Kx9A6c27T0aVXwg7Sy47di7c+El1aVjNgygVGgQJWm7ZX82JA35r+3HjiV33cVfFGppsjlgKnqpk7V+s=)
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
![Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna](https://www.scielo.cl/fbpe/img/rchcir/v65n4/tb04-03.jpg)
Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna
![CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - ScienceDirect CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1470204508700019-gr1.gif)
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - ScienceDirect
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![CA 19-9 assay values in healthy pregnant women. Vertical point plot of... | Download Scientific Diagram CA 19-9 assay values in healthy pregnant women. Vertical point plot of... | Download Scientific Diagram](https://www.researchgate.net/publication/51524275/figure/fig3/AS:394144741642246@1470982837427/CA-19-9-assay-values-in-healthy-pregnant-women-Vertical-point-plot-of-all-CA-19-9.png)
CA 19-9 assay values in healthy pregnant women. Vertical point plot of... | Download Scientific Diagram
![PDF) Dosage des marqueurs tumoraux ACE, CA 15.3, CA 125 et CA 19.9 dans les liquides dépanchement et le LCR par immunoanalyse en phase homogène. Corrélation avec les résultats cytologiques et les PDF) Dosage des marqueurs tumoraux ACE, CA 15.3, CA 125 et CA 19.9 dans les liquides dépanchement et le LCR par immunoanalyse en phase homogène. Corrélation avec les résultats cytologiques et les](https://0.academia-photos.com/attachment_thumbnails/49974895/mini_magick20180818-30286-t5ovbv.png?1534589575)
PDF) Dosage des marqueurs tumoraux ACE, CA 15.3, CA 125 et CA 19.9 dans les liquides dépanchement et le LCR par immunoanalyse en phase homogène. Corrélation avec les résultats cytologiques et les
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig2_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna](https://www.scielo.cl/fbpe/img/rchcir/v65n4/tb04-01.jpg)
Rendimiento diagnóstico del marcador tumoral CA 19-9 en la diferenciación entre patología bilio-pancreática benigna y maligna
![Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3.jpg)